Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PDCD1LG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ARX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPR78 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC401312 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM132C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAS1RR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LRRC37A7P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PER3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FIBIN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MILR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NID1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAPK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NOL7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFYB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORA71A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASGR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on